Antagonizing STK25 Signaling Suppresses the Development of Hepatocellular Carcinoma Through Targeting Metabolic, Inflammatory, and Pro-Oncogenic Pathways

Llovet, 2016, Hepatocellular carcinoma, Nat Rev Dis Primers, 2, 16018, 10.1038/nrdp.2016.18 Friedman, 2014, Focus. We’ve hit the iceberg – the threat of NASH-related HCC arrives, J Hepatol, 60, 1, 10.1016/j.jhep.2013.10.003 Dyson, 2014, Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team, J Hepatol, 60, 110, 10.1016/j.jhep.2013.08.011 Anstee, 2013, Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis, Nat Rev Gastroenterol Hepatol, 10, 330, 10.1038/nrgastro.2013.41 Sanyal, 2010, Population-based risk factors and resource utilization for HCC: US perspective, Curr Med Res Opin, 26, 2183, 10.1185/03007995.2010.506375 Chalasani, 2018, The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases, Hepatology, 67, 328, 10.1002/hep.29367 Schuster, 2018, Triggering and resolution of inflammation in NASH, Nat Rev Gastroenterol Hepatol, 15, 349, 10.1038/s41575-018-0009-6 Anstee, 2019, From NASH to HCC: current concepts and future challenges, Nat Rev Gastroenterol Hepatol, 16, 411, 10.1038/s41575-019-0145-7 Wong, 2015, Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States, Gastroenterology, 148, 547, 10.1053/j.gastro.2014.11.039 Mittal, 2015, Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population, Clin Gastroenterol Hepatol, 13, 594, 10.1016/j.cgh.2014.08.013 Amrutkar, 2015, Genetic disruption of protein kinase STK25 ameliorates metabolic defects in a diet-induced type 2 diabetes model, Diabetes, 64, 2791, 10.2337/db15-0060 Amrutkar, 2015, Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH, FASEB J, 29, 1564, 10.1096/fj.14-264937 Amrutkar, 2016, STK25 is a critical determinant in nonalcoholic steatohepatitis, FASEB J, 30, 3628, 10.1096/fj.201600562R Amrutkar, 2016, Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans, Diabetologia, 59, 341, 10.1007/s00125-015-3801-7 Cansby, 2019, Targeted delivery of Stk25 antisense oligonucleotides to hepatocytes protects mice against nonalcoholic fatty liver disease, Cell Mol Gastroenterol Hepatol, 7, 597, 10.1016/j.jcmgh.2018.12.004 Nunez-Duran, 2018, Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice, Hepatol Commun, 2, 69, 10.1002/hep4.1128 Nerstedt, 2020, Lipid droplet-associated kinase STK25 regulates peroxisomal activity and metabolic stress response in steatotic liver, J Lipid Res, 61, 178, 10.1194/jlr.RA119000316 Ueno, 2017, Autophagy in the liver: functions in health and disease, Nat Rev Gastroenterol Hepatol, 14, 170, 10.1038/nrgastro.2016.185 Lebeaupin, 2018, Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease, J Hepatol, 69, 927, 10.1016/j.jhep.2018.06.008 Verna, 1996, N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation, Pharmacol Ther, 71, 57, 10.1016/0163-7258(96)00062-9 Brown, 2018, Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research, Nat Rev Gastroenterol Hepatol, 15, 536, 10.1038/s41575-018-0033-6 De Minicis, 2014, HCC development is associated to peripheral insulin resistance in a mouse model of NASH, PLoS One, 9, 10.1371/journal.pone.0097136 Miura, 2010, Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice, Gastroenterology, 139, 323, 10.1053/j.gastro.2010.03.052 Yang, 2017, TRIF differentially regulates hepatic steatosis and inflammation/fibrosis in mice, Cell Mol Gastroenterol Hepatol, 3, 469, 10.1016/j.jcmgh.2016.12.004 Liu, 2013, Animal models of chronic liver diseases, Am J Physiol Gastrointest Liver Physiol, 304, G449, 10.1152/ajpgi.00199.2012 Constandinou, 2005, Modeling liver fibrosis in rodents, Methods Mol Med, 117, 237 Matsuki, 2013, Acute inactivation of the serine-threonine kinase Stk25 disrupts neuronal migration, Neural Dev, 8, 21, 10.1186/1749-8104-8-21 Liang, 2019, NADPH oxidase 1 in liver macrophages promotes inflammation and tumor development in mice, Gastroenterology, 156, 1156, 10.1053/j.gastro.2018.11.019 Fitamant, 2015, YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression, Cell Rep, 10, 1692, 10.1016/j.celrep.2015.02.027 Grohmann, 2018, Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC, Cell, 175, 1289, 10.1016/j.cell.2018.09.053 Naugler, 2007, Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production, Science, 317, 121, 10.1126/science.1140485 Maeda, 2005, IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis, Cell, 121, 977, 10.1016/j.cell.2005.04.014 Nakagawa, 2014, ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development, Cancer Cell, 26, 331, 10.1016/j.ccr.2014.07.001 Sakurai, 2008, Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis, Cancer Cell, 14, 156, 10.1016/j.ccr.2008.06.016 Bergmann, 2017, IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice, Hepatology, 65, 89, 10.1002/hep.28874 Zhu, 2011, HCC and angiogenesis: possible targets and future directions, Nat Rev Clin Oncol, 8, 292, 10.1038/nrclinonc.2011.30 Tacke, 2014, Macrophage heterogeneity in liver injury and fibrosis, J Hepatol, 60, 1090, 10.1016/j.jhep.2013.12.025 Hernandez-Gea, 2013, Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma, Gastroenterology, 144, 512, 10.1053/j.gastro.2013.01.002 Li, 2019, FUN14 domain-containing 1-mediated mitophagy suppresses hepatocarcinogenesis by inhibition of inflammasome activation in mice, Hepatology, 69, 604, 10.1002/hep.30191 Zuo, 2021, PGC1alpha suppresses metastasis of HCC by inhibiting Warburg effect via PPARgamma-dependent WNT/beta-catenin/PDK1 axis, Hepatology, 73, 644, 10.1002/hep.31280 Min, 2011, Mitogen-activated protein kinases in hepatocellular carcinoma development, Semin Cancer Biol, 21, 10, 10.1016/j.semcancer.2010.10.011 Calvisi, 2006, Ubiquitous activation of Ras and Jak/Stat pathways in human HCC, Gastroenterology, 130, 1117, 10.1053/j.gastro.2006.01.006 Li, 2015, CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARalpha pathways, J Hepatol, 63, 1378, 10.1016/j.jhep.2015.07.039 Luk, 2020, Deficiency in embryonic stem cell marker reduced expression 1 activates mitogen-activated protein kinase kinase 6-dependent p38 mitogen-activated protein kinase signaling to drive hepatocarcinogenesis, Hepatology, 72, 183, 10.1002/hep.31020 Sakurai, 2006, Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation, Proc Natl Acad Sci U S A, 103, 10544, 10.1073/pnas.0603499103 He, 2010, Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation, Cancer Cell, 17, 286, 10.1016/j.ccr.2009.12.048 Nieto, 2016, Emt: 2016, Cell, 166, 21, 10.1016/j.cell.2016.06.028 Ryerson, 2016, Annual report to the nation on the status of cancer, 1975-2012, featuring the increasing incidence of liver cancer, Cancer, 122, 1312, 10.1002/cncr.29936 Thomas, 2005, Hepatocellular carcinoma: the need for progress, J Clin Oncol, 23, 2892, 10.1200/JCO.2005.03.196 Giannelli, 2016, Role of epithelial to mesenchymal transition in hepatocellular carcinoma, J Hepatol, 65, 798, 10.1016/j.jhep.2016.05.007 Lim, 2019, Identification of the kinase STK25 as an upstream activator of LATS signaling, Nat Commun, 10, 1547, 10.1038/s41467-019-09597-w Bae, 2020, STK25 suppresses Hippo signaling by regulating SAV1-STRIPAK antagonism, Elife, 9, 10.7554/eLife.54863 Uhlen, 2015, Proteomics. Tissue-based map of the human proteome, Science, 347, 10.1126/science.1260419 Cansby, 2019, Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans, FASEB J, 33, 9974, 10.1096/fj.201900356RR Caputo, 2021, STE20-type protein kinase MST4 controls NAFLD progression by regulating lipid droplet dynamics and metabolic stress in hepatocytes, Hepatol Commun, 5, 1183, 10.1002/hep4.1702 Caputo, 2021, Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease, FASEB J, 35, 10.1096/fj.202002671RR Cansby, 2013, Increased expression of STK25 leads to impaired glucose utilization and insulin sensitivity in mice challenged with a high-fat diet, FASEB J, 27, 3660, 10.1096/fj.13-228494